The Annual Report for the Financial Year 2024-25 is sent to the shareholders on July 04, 2025 and BSE is hereby intimated about the same.
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India Ltd has informed the BSE that its Annual Report for the financial year 2024-25 has been sent to shareholders on July 04, 2025. This is a routine regulatory disclosure confirming that the annual report has been dispatched as required under listing norms. The actual financial details and business performance will be available in the annual report itself. No new material information or corporate action is being announced through this filing.
This is a routine compliance filing with no direct impact on the stock price or shareholder value. Investors can review the annual report for detailed financial performance, management discussion, and future outlook of the company.